Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cellana is a private U.S. algae biotechnology company developing and commercializing microalgae-based products for human nutrition, animal feed, and biofuel applications. Its core business centers on marine microalgae cultivation and downstream processing to produce the ReNew product line, including omega-3 EPA and DHA oils, algae meal, and biofuel feedstocks. The company's proprietary ALDUO platform combines photobioreactors with open ponds to enable large-scale outdoor production of diverse non-GMO algae strains. Cellana has operated a demonstration facility in Hawaii and is pursuing commercialization of integrated algae biorefineries in multiple geographies. In recent years, the company has also expanded toward consumer nutrition through a merger agreement with PhytoSmart.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cellana.